Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 24 July 2016

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Liver transplantation influences fatigue in patients with primary biliary cirrhosis

A study in the latest issue of the Journal of Hepatology investigates the effect of liver transplantation on fatigue in patients with primary biliary cirrhosis.

News image

The role of liver transplantation for the relief of fatigue in patients with primary primary biliary cirrhosis is unclear.

While many centers exclude fatigue as an indication for transplantation, there have been no studies to prospectively evaluate the impact of liver transplantation on fatigue.

Dr Marco Carbone and colleagues assessed the severity of fatigue in liver transplantation candidates with primary biliary cirrhosis and the impact of liver transplantation on fatigue.

In a prospective, longitudinal study, the team used the primary biliary cirrhosis-40 questionnaire in 49 adult patients with primary biliary cirrhosis at listing and at 6, 12, and 24 months after liver transplantation.

The team also assessed 2 sex- and age-matched cohorts of community controls, and non-transplanted primary biliary cirrhosis patients.

The calculated pooled gastric cancer incidence-rate was about 0.3% per person-years
Journal of Hepatology

Correlation analysis was used to assess the relationship between liver function and fatigue.

ANOVA was used to compare the variation of fatigue score before and after liver transplantation.

There was no correlation between MELD and fatigue before liver transplantation.

The doctors found that overall, the fatigue score after liver transplantation was substantially lower than before liver transplantation, falling from 41 pre-transplant to 28, 29, 26 at 6, 12, and 24 months after liver transplantation, respectively.

The same improvement of fatigue was observed in both low-MELD and high-MELD patients.

The team noted that improvement in fatigue was also evident in the comparison with a “non-transplant primary biliary cirrhosis” control group.

However, 44% of the total cohort, and 47% of those with low-MELD, for whom the probability of dying of liver transplantation may be higher than that of dying without liver transplantation, had moderate to severe fatigue at 2 years after liver transplantation.

Moreover, fatigue scores at 2 years were higher in the transplant primary biliary cirrhosis cohort compared to a cohort of community controls.

Dr Carbone's team concludes, "Liver transplantation is associated with improvement in fatigue in patients with primary biliary cirrhosis."

"However, a substantial proportion of patients continue to suffer from significant fatigue after two years."

"Whether the improvement is enough to justify organ allocation in patients with fatigue alone, without liver failure, is still an open issue."

"Certainly, in the era of organ shortage, with many patients dying waiting for a graft, this may not represent the optimal use of donated deceased organs."

J of Hepatol 2013: 59(3): 490-494
23 September 2013

Go to top of page Email this page Email this page to a colleague

 22 July 2016 
Fecal calprotectin and IBD
 22 July 2016 
Duodenal villous atrophy and celiac disease
 22 July 2016 
Upper GI lesions at primary diagnosis in IBD
 21 July 2016 
Radiofrequency ablation in Barrett's
 21 July 2016 
HCV eradication and inflammation in cirrhotic patients
 21 July 2016 
Surveillance of Barrett's
 20 July 2016 
Nonselective β-blockers and survival in cirrhosis
 20 July 2016 
Adolescent body mass index and and colorectal cancer risk
 20 July 2016 
Genetic biomarkers and IBD treatment response
 19 July 2016 
Prevention of chemotherapy-induced nausea and vomiting
 19 July 2016 
Longterm clinical follow-up of living liver donors
 19 July 2016 
Screening diabetic patients for NAFLD
 18 July 2016 
Rectal neuroendocrine tumors
 18 July 2016 
Liver stiffness measurement in chronic liver disease
 18 July 2016 
Liver cancer prediction scores in Hep B
 15 July 2016 
Patient reported outcomes in celiac disease
 15 July 2016 
Tonsillectomy and IBD risk
 15 July 2016 
Trainee IBD education in the USA
 14 July 2016 
Screening for familial pancreatic cancer
 14 July 2016 
Fecal calprotection for IBD prognosis
 14 July 2016 
Perianal surgery risk in Crohn's
 13 July 2016 
Lung transplant outcomes in Hep C
 13 July 2016 
Psychological comorbidity and postinfectious IBS
 13 July 2016 
Graft selection strategy in living donor liver transplants
 12 July 2016 
Treatment of pediatric acute liver failure
 12 July 2016 
Therapy for iron deficiency anemia in IBD
 12 July 2016 
Surveillance endoscopy in Barrett's esophagus
 11 July 2016 
Disturbed sleep and IBS
 11 July 2016 
Transition to adulthood in celiac disease
 11 July 2016 
Factors that influence access to liver transplant
 08 July 2016 
Mortality and peptic ulcers
 08 July 2016 
Statins and cirrhosis in Hep B
 08 July 2016 
Genetic risk score and body mass index
 07 July 2016 
Predicting food triggers in eosinophilic esophagitis
 07 July 2016 
Extraperitoneal vs transperitoneal colostomy for hernia
 07 July 2016 
Predictors fecal transplant failure in C. diff infection
 06 July 2016 
Therapies for Hep B cure
 06 July 2016 
Hospital volume and liver cancer survival
 06 July 2016 
Adverse events after outpatient colonoscopy
 05 July 2016 
Colorectal surgery and dialysis
 05 July 2016 
Non-invasive scoring systems for fibrosis in NAFLD
 05 July 2016 
Exercise and gastroesophageal reflux
 04 July 2016 
Guidelines on PPI and NSAID prescription
 04 July 2016 
Rectal cancer surgery checklist
 04 July 2016 
Autoimmunity in eosinophilic esophagitis and families
 01 July 2016 
Outcome measures in celiac disease
 01 July 2016 
Growth factor activity and IBD
 01 July 2016 
Aspirin and colorectal cancer
 30 June 2016 
Staging system for familial adenomatous polyposis
 30 June 2016 
Antibiotics in children and obesity
 30 June 2016 
IBS-type symptoms in pediatric IBD
 29 June 2016 
Hep C eradication in people who inject drugs
 29 June 2016 
Anti-tumor necrosis factor in mothers and newborns
 29 June 2016 
Progression to esophageal carcinoma in Barrett's
 28 June 2016 
Gastric cancer screening in the USA
 28 June 2016 
Cancer recurrence after immune-suppressive therapies
 28 June 2016 
Acute severe ulcerative colitis
 27 June 2016 
Tobacco smoking and ulcerative colitis
 27 June 2016 
Epidemiology of NAFLD
 27 June 2016 
The Toronto Consensus for H. pylori treatment

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2016 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us